Ambu's visualization devices can be used for a wide range of airway procedures
Critically ill patients on mechanical ventilation face a number of risks during hospitalization in the ICU. BAL is an excellent procedure for timely and accurate diagnosis. But, do you always have immediate access to a flexible bronchoscope when needed?
To overcome the challenges of proper placement and positioning of double lumen tubes or endobronchial blockers visual guidance is recommended as good clinical practice. The VivaSight portfolio makes OLV fast and effective and increases patient safety.
One of the most common uses of bronchoscopy in the ICU is management of retained secretions and atelectasis. Visual guidance using a aScope 4 Broncho Large ensures efficient and safe removal of secretion without risk of damaging the bronchial mucosa.
Bronchoscopy guidance during PDT enhances patient safety. aScope 3 has clear cost advantages as it eliminates all repair costs normally associated with use of bronchoscopes for PDT. Further, it eliminates the risk of cross-contamination.
Clinical studies document the benefits of adding advanced visualization equipment to the toolbox of airway management. aScope 4 Broncho and King Vision are the ideal choice for all types of intubation.
Limited access to train flexible intubation and bronchoscopy skills is a challenge due to lack of equipment and fear of damaging expensive scope systems. With aScope 3 you no longer have to worry about occupying equipment, expensive repair and reprocessing.
ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBPAGE BY AMBU A/S (THE “COMPANY”) IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY. THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN THE UNITED STATES, CANADA, AUSTRALIA AND JAPAN AND ANY OTHER JURISDICTION WHERE THE EXTENSION OR AVAILABILITY OF THE PROPOSED OFFERING (AND ANY OTHER TRANSACTION CONTEMPLATED THEREBY) WOULD BREACH ANY APPLICABLE LAW OR REGULATION (THE “RESTRICTED JURISDICTIONS”).
Please read this notice carefully — it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated from time to time. You should read it in full each time you visit the site.
Access to electronic versions of these materials is being made available by the Company in good faith and for information purposes only. Any person seeking access to this webpage represents and warrants to the Company that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy the securities mentioned in such materials (the “Securities”). Further, it does not constitute a recommendation by the Company or any other party to sell or buy the Securities.
Viewing the materials on this webpage may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any citizens or residents or, or persons otherwise located in, any Restricted Jurisdiction, who wish to view these materials should satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so.
Unless otherwise determined by the Company and permitted by applicable law and regulation, the materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for the Securities by the Company made in the Restricted Jurisdictions or any other jurisdiction in which such offers or sales are unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
In particular, the Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States or the other Restricted Jurisdictions. Accordingly, unless an exemption under the relevant securities law is applicable, the Securities may not be offered, sold, taken up, exercised, renounced, resold, delivered or distributed, directly or indirectly, in or into the United States or the other Restricted Jurisdictions or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of the Securities in, such jurisdiction. There will be no public offering of the Securities in the United States.
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
Electronic versions of these materials are not directed at or accessible by, nor should they be made available to, persons located in the Restricted Jurisdictions or in any other restricted jurisdiction.
By clicking on the “Agree” button, I certify that I am not located in any of the Restricted Jurisdictions or in any other restricted jurisdiction.
I have read and understood the disclaimer set out above. I understand that it may affect my rights. I agree to be bound by its terms. By clicking on the “Agree” button, I confirm that I am permitted to proceed to electronic versions of these materials.